Dr. Leen Kawas, a trailblazer in the biotechnology industry, has made significant strides in her career, transitioning from a pharmacist to a successful entrepreneur and leader. In a recent appearance on the Recruitomics Consulting Podcast, Dr. Kawas shared valuable insights into her approach to building effective teams, the importance of diversity in clinical trials, and the need for patient involvement in drug development. Managing General Partner of Propel Bio Partners, Dr. Leen Kawas, is focused on recruiting the right individuals to support the company’s growth. She emphasizes the importance of a growth mindset and a “beginner’s mindset” when evaluating candidates. Dr. Kawas believes that people who liare ve, eager people toand approachpproachh problems with a fresh perspective are invaluable assets to any team. Additionally, she recognizes the value of hiring newer professionals in the biotech industry, as they bring unique ideas and enthusiasm to the workplace. Dr. Kawas also stresses the importance of creating a fun environment to foster collaboration and the successful execution of ideas.
In the realm of clinical trials, Dr. Leen Kawas is a strong advocate for increased diversity. She believes that having a diverse management team, particularly with more female and minority representation, is crucial for the success of clinical trials and the recruitment of the right patient population. Dr. Kawas also emphasizes the need for diversity in patient selection, as it provides a more accurate representation of how a drug will impact a significant portion of society. By achieving these goals, drug developers can not only make a significant impact on humanity but also generate substantial returns on their investments.
Dr. Leen Kawas has been a long-standing proponent of patient involvement in the drug development cycle. She believes that patients should be an integral part of every phase, from drug discovery to development, rather than being involved only towards the end of the process. Dr. Kawas’ commitment to this cause began several years ago when she and her colleagues conducted patient feedback sessions to understand why certain drugs fail. By including the patients’ voices in the clinical design, Dr. Kawas aims to improve outcomes and ensure that the developed drugs meet the needs of those who will ultimately benefit from them.
Looking ahead, Dr. Leen Kawas has ambitious goals for the next decade. She aspires to invest in companies that aring technologies to improve human health on a global scale. Furthermore, Dr. Kawas is dedicated to providing internship opportunities for students and recent graduates from diverse backgrounds, recognizing the importance of fostering talent and promoting inclusivity in the biotechnology industry. Lastly, she is committed to giving back to future entrepreneurs, acknowledging the support she received throughout her own carcareer journey and its impact success.
Dr. Leen Kawas’ remarkable journey in the biotechnology industry serves inspiresng professionals and entrepreneurs. Her unwavering commitment to diversity, patient involvement, and fosteritalent fosteringsitioned her as a visionary leader in the field. As she continues to drive Propel Bio Partners forward, Dr. Kawas’ impact on the industry and the lives of countless individuals is sure to be profound and far-reaching.
